Small Molecules
Total Trials
7
As Lead Sponsor
6
As Collaborator
1
Total Enrollment
1,593
NCT01387750
Mentholated Cream Containing Oxygenated Glycerol Triesters on Acute Pain of the Muscles and Joints
Phase: Phase 1/2
Role: Collaborator
Start: May 31, 2007
Completion: Jun 30, 2007
NCT01780428
Phase III Study of the Safety and Efficacy of Cl-108 in the Treatment of Moderate to Severe Pain
Phase: Phase 3
Role: Lead Sponsor
Start: Jan 31, 2013
Completion: Dec 31, 2014
NCT02462850
A Multi-Center Actual-Use Study on the Safety of CL 108 for the Treatment of Moderate to Severe Acute Pain Associated With Osteoarthritis of the Knee or Hip
Start: Oct 31, 2014
Completion: Feb 28, 2015
NCT02465866
A Four-Period, Four-Treatment, Four-Way Relative Bioavailability Study of CL-108 Under Fed and Fasted Conditions
Phase: Phase 1
Start: Nov 30, 2014
Completion: Apr 30, 2015
NCT02712554
A Study in Opioid-Experienced, Non-Dependent Recreational Drug Users to Determine the Abuse Potential and Safety of CL-108 Tablets Administered Via the Oral Route
Start: Jun 30, 2015
Completion: Sep 30, 2015
NCT03657810
A Controlled Study to Determine the Efficacy and Safety of CL-108 5 mg for Acute Pain and the Prevention of OINV
Start: Aug 2, 2017
Completion: Nov 30, 2018
NCT03877718
A Study to Assess the Efficacy and Safety of Oral CL-H1T in the Treatment of Acute Migraine Pain
Phase: Phase 2
Start: Feb 1, 2019
Completion: Aug 27, 2019
Loading map...